Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Camurati-Engelmann Syndrome × bintrafusp alfa protein, human × Clear all

Phase

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 4 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Hematologic Neoplasms 1 Camurati-Engelmann Syndrome 1 Brain Neoplasms 1

Interventions

enzalutamide 1 bintrafusp alfa protein, human 1 Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04297748 2023-01-17

Bioimaging Study of 89Zr-M7824 in NSCLC

Olivia Newton-John Cancer Research Institute

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung, Camurati-Engelmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡